Abstract. Marginal structural models were introduced in order to provide estimates of causal effects from interventions based on observational studies in epidemiological research. The key point is that this can be understood in terms of Girsanov's change of measure. This offers a mathematical interpretation of marginal structural models that has not been available before. We consider both a model of an observational study and a model of a hypothetical randomized trial. These models correspond to different martingale measures, the observational measure and the randomized trial measure, on some underlying space. We describe situations where the randomized trial measure is absolutely continuous with respect to the observational measure. The resulting continuous time likelihood ratio process with respect to these two probability measures corresponds to the weights in discrete time marginal structural models. In order to do inference for the hypothetical randomized trial, we can simulate samples using observational data weighted by this likelihood ratio.
Introduction
We will consider the following scenario: A patient has a disease. In order to avoid an event as for instance death, a specific treatment can be given. The given treatment will typically depend on the patient's previous health condition.
We would like to estimate the effect of a given treatment on the time to the occurrence of the event. A natural way to do so is to implement some sort of randomized trial. This means that we would have to set up an experiment on a group of patients where the treatment was initiated by randomization independently of each patient's previous health condition. Such a study typically require a lot of resources and may not be available. In order to take advantage of another type of data, we could try to base our estimates of the treatment effect on an observational study. Suppose we have observations of a group of patients where the given treatments were chosen by doctors. As a first attempt, one could try to compute the relative short-term risk between the group given treatment and the group not given treatment at a time. This could for instance be done using Cox proportional hazards regression techniques. However, such a naive analysis would most likely introduce a bias compared to the estimate based on the randomized trial. The reason is that the health condition of the patient not already on treatment will be a predictor of both treatment and death, i.e. it is likely to be a confounder [SHL + 05]. We can easily imagine two opposite scenarios where this confounder would complicate estimates: Due to considerable costs, reduced life quality or possibly drug resistance, one could decide that the treatment should not be initiated until the patients are sufficiently ill. A naive marginal analysis based on data from an observational study would then quickly lead us to believe that the treatment effect was less than the true treatment effect. Conversely, if we for some reason decided only to initiate treatment for patients with a good health condition and not for the ones with a poor condition, then a naive marginal analysis would quickly lead us to believe that the treatment effect was better than the true treatment effect.
In order to solve this problem, one might suggest to compute an estimate of the treatment effect conditionally on the health condition of the patient. However, in several situations, it is likely that the previous treatment will improve the patient's general intermediate health condition. This improvement will in itself typically postpone the time of death. The conditional effect estimate we described would only incorporate the direct treatment effect, not the effect that is due to an improvement of the patient's intermediate health condition.
There is also another source of bias that we have to consider in order to lay hands on the causal effect of treatment, that is censoring. We assume that a patient may drop out of the study at a time and not return, i.e. we have right censoring. The given treatment, calender time and the patient's health condition might lead to such a drop out. If we do a naive analysis based on the patients that are still in the study, then we introduce a selection bias [HHDR04] .
We are forced to move outside the standard Cox regression framework since we have to deal with the mentioned time dependent confounder effects due to a patient's underlying health condition. In order to provide a meaningful estimate of the treatment effect, with a simple interpretation, we could try to construct a rich model that also describes the dynamics of the underlying biological processes. Such mechanisms are likely to be very complicated and there might not be sufficient knowledge or data available. For this reason we could try to fit a marginal model of a suitable randomized trial for our scenario. This will be our strategy in what follows.
One attempt to provide a marginal estimate of the causal treatment effect this way is due to J. Robins and is presented in [RHB00] . This method uses marginal structural models and relies on the additional assumption that there are no unmeasured confounders, i.e. there does not exist an unobserved process that is a predictor of both censoring and treatment, both censoring and event or both treatment and event, given the observed covariates. If every such process is measured, then the MSM approach provides a proper adjustment of the marginal effect estimates. The idea is to apply some clever weights to the observations. This weighting results in a pseudo population that is different from the observed population. The key property of this pseudo population is that the selection bias and the treatment confounding due to the patient's health condition become negligible. Now, one can for instance proceed with a weighted Cox regression to obtain a marginal estimate of the effect of treatment. The method has been used several times on epidemiological studies. In [HBR00] it was used to estimate the effect of Zidovudine on the survival of HIV-Positive men in the Multi center AIDS Cohort Study. Moreover, the method was also used in [SHL + 05] to give an estimate of the hazard ratio for the effect of highly active antiviral treatment (HAART) on progression to AIDS or death for HIV patients in Switzerland.
The method introduced by J. Robins deals with longitudinal data in discrete time. We will consider continuous time versions of the marginal structural models for event history data. The idea is to characterize reasonable models of a randomized trial, the randomized trial measures, using martingale theory. This offers a mathematical interpretation of marginal structural models that has not been available before.
We characterize a class of of reasonable models of randomized trials in terms of local independence. Such a model corresponds to a particular martingale measure. The continuous time likelihood ratio process between this measure and the observational probability measure corresponds to the weights in a discrete time marginal structural model. In order to do inference for this new measure, we can simulate samples using the observed data weighted by this likelihood ratio.
Another approach to causal inference within our scenario is to use the so called structural nested models. These models were also introduced by J. Robins, see [Rob92] and [Rob98] . J. Lok has developed continuous time versions of such models, using counting processes and martingale theory, see [Lok08] .
Observable processes and local independence
Before we come to the main results, we will spend some time to establish terminology. Even if the mathematics involved is fairly standard stochastic process theory, it is perhaps not so commonly used in event history analysis. A very good background reference on stochastic processes, that we will use many times, is [JS03] .
2.1. Observable processes. In section 3 we will consider a stochastic model of a single patient. There are typically many factors that are important for describing how the disease of that individual develops in time. We will consider models where all the possible observations of one patient are represented by stochastic integrals against Poisson processes. More formally, let d, n ∈ N and consider a probability space (Ω, F , Q) with mutually orthogonal counting processes N 1 t , . . . , N n t on the interval [0, T ] and a filtration {F t } t that is generated by their joint history and some initial information F 0 . The counting processes are assumed to be Poisson processes in the sense that
. . , N n t := N n t − t define Q-martingales, the compensated Poisson processes. The probability measure Q will only play a role as a reference measure, as we will mainly be interested in probability measures that are absolutely continuous with respect to Q. This will some times be referred to as the Poisson measure.
We let H be a bounded and F t -predictable d × n-matrix valued process and let X 0 denote a bounded F 0 -measurable random vector. Now, define the d-dimensional observable process :
All the possible observations of a patient in our approach will be processes of this form. Counting processes are trivially included in this class, but we also allow slightly more complicated jump processes. One example could be measurements of blood values. Each time the blood value is updated would be given by a jump and corresponds to a jump time of the underlying counting process. The size and direction of the jump would then be given by the value of the predictable integrand H at the jump time.
2.2. Separability. We will say that two observable processes X and Y are separable if they allow the representations:
where N X and N Y are independent components of the multivariate process N , X 0 and Y 0 are bounded F 0 -measurable random vectors and H X and H Y are bounded matrix valued processes that are predictable with respect to the histories of N X and N Y respectively. Separability is a technical assumption that provides well behaved factorizations of likelihoods. This is used in the proof of Theorem 1. Heuristically, it means that the processes X and Y do reflect different random phenomena. Separability is even stronger than orthogonality since the processes are independent with respect to the Poisson measure Q. However, since we will deal with other probability measures that are absolutely continuous with respect to the Poisson measure, separable processes can not necessarily be treated as independent.
2.3. A martingale measure. As we have mentioned earlier, our samples will consist of paths of observable processes. These samples will be distributed according to some probability measure P such that a given family of predictable and non negative processes define the jump intensities for N 1 , . . . , N n with respect to F t . Since we assume that the observations are distributed according to P , we will refer to such a measure as an observational measure.
More formally, we let λ 1 , . . . , λ n be non-negative F t -predictable processes and we assume that P is a probability measure such that:
(1) P and Q coincide on F 0 , (2) P ≪ Q, i.e. P is absolutely continuous with respect to the Poisson measure, (3) The equation
defines a square integrable P -martingale with respect to F t for every i.
These properties characterize the probability measure P uniquely if such a measure exists, [JS03, Theorem III 1.26].
2.4. Non-influence. We will need a notion of non-influence between observable processes. There are several formal definitions that are meant to capture this, see [FF96] . Independence, or even conditional independence, is too strong to be of interest for the method we have in mind. The non-influence relation we will consider is local independence. Heuristically, a process X is locally independent of a process Y if information about the past of Y does not contribute to a better prediction of the short term behavior of X.
In the setting of event history analysis, this concept has been studied thoroughly by V. Didelez, [Did08] . T. Schweder [Sch70] used this concept in a study of composable Markov processes. O. Aalen et. al made use of local independence in order to study the effect of menopause on the risk of developing a certain skin disease in [AKT80] .
2.5. Local independence. Let X, Y, Z be observable processes that are mutually separable. The processes X t − X 0 , Y t − Y 0 and Z t − Z 0 are obviously independent with respect to the probability measure Q. However, the situation is typically more complex with respect to the measure P , since the jump intensities λ 1 t , . . . , λ n t could depend on all the information in F t− . We therefore introduce the following concept:
denote the filtration generated by N X , N Y , N Z and let F X,Z t denote the filtration generated by N X and N Z . We say that X is locally independent of Y , given Z, if there exists an F X,Z t -predictable process µ such that
. If this is the case, then we write:
2.6. Independent censoring. Local independence generalizes a much used concept in event history analysis, that is independent censoring. Suppose we can follow a group of individuals in a clinical trial. We would like to compute the probability for an individual to survive longer than time t. However, an individual might be censored at some time before the event due to the end of the study or a "drop-out". Inference is much simpler if the censoring does not influence the instantaneous risk of the event. Therefore it is common to assume independent censoring. This means that an individual at risk have the same instantaneous risk of an event as he would in the situation without censoring. More formally, this means that if T D is the time of the event and T C is the time of censoring then the compensator of the process D t := I(t ≥ T D ) with respect to the joint event and censoring history only depends on the event history. This is essentially the same as saying that D is locally independent of the process defined by C t := I(t ≥ T C ).
2.7. Local independence before a stopping time. Sometimes we may not be interested in dependencies that are considered trivial. This could for instance be dependencies due to an absorbing state as for instance death. We will see that we can rule out such trivial dependencies if we consider local independence before a stopping time τ .
Definition 2. Let τ be an F t -adapted stopping time. We say that X is locally independent of Y before τ and given Z if there exists an {F -predictable processγ such that γ S · I(S ≤ τ ) =γ S · I(S ≤ τ ) P a.s. for every F t -adapted stopping time S. This means that Y τ X|Z, i.e. stopping at the first jump of N Y rules out every local dependence of Y .
2.8. Local independence graphs. V. Didelez also considered graphical models based on local independence, see [Did08] . These graphs will prove to be very useful in order to represent complex models Definition 3. We say that a directed graph G = (E, V ) is a local independence graph if the vertexes correspond to observable processes that are mutually separable and such that
Several examples of such graphs will appear below.
Models of clinical trials
3.1. A patient model. We will now describe a model of a single patient that participates in a clinical study. We suppose that N is on the form
where N A , N C , N D are univariate counting processes and N L is a multivariate counting process. These counting processes count various events that are important for the development of the disease. 
be the event process. It jumps from 0 to 1 at the time the event occur. The event could be death or for instance progression to AIDS for an HIV patient.
3.1.2. Measurements of the underlying biological process. The state of an underlying biological process reflecting the patient's health condition at time t is given by
where L 0 is a bounded F 0 -measurable random vector and H L is a matrix-valued, bounded and F L t -predictable process. The process L could for instance be measurements of various blood values.
3.1.3. Right censoring. We assume that the patient can be right censored, i.e. we will not be able to observe the patient after some stopping time T C . This can happen because the study ends, but it can also be a "drop-out" due to poor health or recovery. We assume that T C := inf{s > 0|N C s = 0} and define the censoring process
3.1.4. The treatment process. One can switch between two treatments of the patient at the stopping time T A . This could typically be to initiate treatment for a patient at risk. We let T A := inf{s > 0|N A s = 0} and define the treatment process
Especially this means that the patient will not initially be on treatment. This somewhat limiting assumption can be dropped, but then the considerations around the hypothetical randomized trial at baseline will be much more involved.
3.2. Local independences with respect to the observational measure. The process D influences the other processes. However, we consider these dependencies as trivial. We will consider local independence before T D , because then we will automatically have that
We also assume that the censoring does not carry any information about the short term behavior of the other process that we would not obtain if we left C out of the analysis. In terms of local independence this means that C TD A|D ∪ L, C TD D|A ∪ L and C TD L|A ∪ D. We summarize these local independences in the following local independence graph:
3.3. Randomized trial measures. Our ultimate goal is to provide estimates of the causal effect of a particular treatment based on observations of patients in an observational study.
Hypothetically, one could carry out some randomized trial where the given treatment did not depend on the previous health condition of the patient. If we had observations from such a trial, we could easily provide simple estimators for the causal treatment effect that would not require information about the underlying biological mechanisms. This is however not the case for us, so, based on observations from the observational study, we will try to simulate a counterfactual or hypothetical randomized trial. We assume that we have measurements of all the relevant processes and variables. Especially, we assume that the process L is complete in the sense that it gives rise to every event that affects both the short term behavior of the treatment and the event, both the censoring and the event or both the censoring and the treatment, given the full covariate history. This assumption means that all the confounder processes are measured and is usually referred to as no unmeasured confounders.
In order to provide causal interpretation of simple estimators, we should at least require the hypothetical trial to satisfy the following:
(1) Both the underlying biological process and the event process should dynamically behave in the same way in the counterfactual trial and the observational study, given the full covariate history, (2) One should not allow drop-out due to poor health or recovery, i.e. the censoring should not be directly affected by the underlying health process, given the event and treatment history, (3) Since we consider time dependent treatments, we have to generalize the notion of a randomized trial slightly. In our counterfactual trial, the patient's previous health condition or censoring should not be relevant for the short term behavior of the treatment process. Heuristically, this means that the randomization should act locally in time. The counterfactual trial corresponds to a probability measureP on the space (Ω, F ). We will refer to such a measure as a randomized trial measure. It carries the frequencies of the potential observations in the counterfactual randomized trial. The above requirements can now be translated into the following:
(1) The process M i is a localP -martingale with respect to the filtration {F t } t for every i ∈ D ∪ L. This means that both the processes N L and N D have the same intensity with respect to the randomized trial measureP as with respect to the observational measure P . Moreover, we assume that the observational measure and the randomized trial measure coincide at baseline, i.e. E P H = EP H for every bounded F 0 -measurable random variable H.
(2) The censoring should be locally independent of the underlying health process L with respect toP , given the event and treatment history, (3) The treatment process should be locally independent of the underlying health process L and censoring C with respect toP , given the event history. We summarize the local independence structure with respect to the randomized trial measureP in the following local independence graph:
A construction of reasonable randomized trials is given in Theorem 2. Before we come to that, we will consider censoring in the counterfactual trial. In order to estimate the total treatment effect, we will consider a marginal model where L is unobserved. One natural choice of effect measure in the hypothetical experiment could be the hazard of the event process with respect to the filtration {F A,D t } t . In order to estimate the hazard with respect to this filtration, we could try to estimate the hazard of the event before censoring with respect to the filtration {F A,C,D t } t . If in addition, the event process was locally independent of the censoring, given the treatment process, then these hazards would coincide before censoring, i.e. we would have independent censoring. Especially, this would imply that the censoring would not cause bias in the sense that if we did not pay attention to the underlying biological process then the hazard of the event would not depend on whether the patient had been censored or not. We will see in the next theorem that this is the case for the randomized trial measures. Theorem 1. If P is a randomized trial measure then we have C TD A ∪ D, i.e. we have independent censoring in the marginalized model without L. This gives the following local independence graph:
Proof. The likelihood ratio process variation, so its compensator N i , S is well defined. We can compute that
so we get from Girsanov's theorem, see [JS03, Lemma III 3.14] , that
is a local P -martingale with respect to {F t } t for every i ≤ n. Now
defines a continuous finite variation P -martingale, so µ i = λ i P a.s. a.e. and
s., we have that:
The last equality follows from [Pro05, Theorem II 38]. We now consider filtrations corresponding to the σ-algebras:
It is the unique G tpredictable process such that
for every G t -predictable stopping time S.
The local independence relations:
where S L is G L t -predictable and S C is G C t -predictable. Bayes' theorem now gives that whenever F is G L t− -measurable and bounded then (3.4) E F |G t− = E F |G C t− P a.s. Therefore, if we let F be bounded and G C t -predictable, then we can compute: 
i.e.M D is a P -martingale with respect to the filtration {F -predictable, we also see that (3.5) defines a martingale with respect to {F
Existence of randomized trial measures
We have now come to the construction of randomized trial measures. The idea is to construct a reasonable randomized trial measureP from the observational measure P such thatP ≪ P . The absolute continuity is important since this provides a natural method for simulating the empirical expectation of random variables as if the data was sampled from the counterfactual trial, while actually using P -distributed samples. To get an idea of how this is done, let J ∈ N, let H be a bounded random variable and let ω 1 , . . . , ω J be J independently P -distributed samples from Ω. The law of large numbers then yields:
Heuristically, this means that the likelihood ratio can be viewed as a transformation from the observational study into the counterfactual scenario. There might exist several reasonable counterfactual trials, each corresponding to a choice of a well-behaved treatment and censoring strategies. Given a non-negative F
A,D t -predictable processλ
A and a non-negative F
A,C,D t
-predictable processλ C , we can consider the problem of finding a randomized trial measureP that hasλ A as the F t -intensity of N A andλ C as the F t -intensity of N C . This suggests to say thatλ A is the treatment strategy andλ C is the censoring strategy in the counterfactual trial. We will consider the counterfactual treatment strategy given by the P -intensity of N A with respect to F A,D t
. The counterfactual censoring strategy will be given by the P -intensity of N C with respect to F A,D,C t . This gives a randomized trial measure with a likelihood ratio that heuristically corresponds to the stabilized weights one usually considers in the discrete time marginal structural models, [RHB00] . The problem of finding such a randomized trial measure is a martingale problem. Note that this problem might not have a solution. The next theorem shows that if the counterfactual strategies are not too different from the observed intensities, then there exists a unique corresponding randomized trial measureP .
Theorem 2. Suppose that there exist positive numbers θ 1 and θ 2 such that:
for almost every s P a.s. Letλ A denote the P -intensity of N A with respect to the filtration {F A,D t } t and letλ C denote the P -intensity of N C with respect to the filtration {F A,C,D t } t . The equation
defines a square integrable P -martingale with respect to the filtration {F t } t . Moreover, dP = R T dP defines a randomized trial measure on (Ω, F ) such that the martingale dynamics of the biological processes D and L coincide for the two probability measuresP and P , i.e.
also defineP -martingales with respect to {F t } t .
Proof. We define
By the innovation theorem we have that
By (4.1) and (4.2) we have that
We therefore obtain that:
Since K, K is bounded on the interval [0, T ], [LM78, Theorem II.1] yields that the stochastic exponential R := E(K), given by the SDE:
is square integrable. Nowd P = R T dP defines a probability measureP on (Ω, F ).
Note that we have:
Moreover, Girsanov's theorem [JS03, Lemma III 3.14], gives that these processes define localP -martingales with respect to the filtration {F t } t .
Moreover,
so again by Girsanov's theorem, we have that
defines aP -martingale with respect to the filtration {F t } t . Analogously, we have that
defines a localP -martingale with respect to the filtration {F t } t .
Finally, we note that by [JS03, Theorem I 4.60], the SDE (4.5) has the explicit solution given by (4.3). Expressions of this form are well known in the literature on marked point process, see for instance [Jac75] .
Remark 1. Note that the condition (4.1) heuristically means that the short-term "risk" of starting treatment, given the previous full history,
is not too different from the short-term "risk" of starting treatment, when we do not pay attention to the underlying health process or censoring, i.e.
Similarly, the condition (4.2) heuristically means that the short-term "risk" of being censored, given the previous full history, is not too different from the shortterm "risk" of being censored, when we do not pay attention to the underlying health process. In words, this means that the previous history of the health process L alone can not at any time yield too high short-term "risk" of starting treatment or being censored.
Weighted additive hazard regression
Suppose that we have observations of m independent individuals until death or censoring from an observational study and want to estimate the total effect of treatment. Ideally, we would like to base our estimate on some randomized trial. However, such a trial might not be available. The marginal structural approach now suggests to simulate a counterfactual randomized trial, using the data we already have. We would then like to estimate the counterfactual hazard, i.e. the hazard that the patient would have if he, contrary to the fact, had participated in the randomized trial. In this way we could compare the total effect of being treatment versus never being on treatment before.
We assume that the observations from each individual is P distributed. The observations of the patient would have beenP -distributed if he, contrary to the fact, participated in the hypothetical randomized trial.
We assume that the counterfactual intensity follows Allen's additive hazard regression model, see [ABGK93] and [ABG08] . To formalize this, let β 0 and β 1 be functions on [0, T ]. We assume that we only have instantaneous effect and assume that the hazard for the event, with respect to the treatment and event history is given by: β 
Moreover, let R 1 t , . . . , R m t be the individual likelihood ratios at time t and let converges in probability to β t when m increases. Note that E sup
Concluding remarks
We have shown that marginal structural modeling can be understood in terms of change of probability measures. The author believes that this is an elucidating point of view that is natural in the framework of modern probability theory.
As stressed by several authors, there is a very important and highly non-trivial assumption one has to make in order to interpret effects from marginal structural models as causal. This is the assumption of no unmeasured confounders, or equivalently: all confounders are measured. This means that every process that affects the short-term behavior of both the treatment and the censoring or both the treatment and the event must be observed. In this equivalent form, it becomes more apparent that this is just an assumption about completeness of the model. This completeness assumption is not that mysterious. When modeling various phenomena in the natural sciences one typically assumes that all the important variables are contained in the model. This is also necessary in the MSM approach. However, it is important to note that this is not in general a statistically testable assumption. It is neither a condition that would follow from a mathematical argument without further assumptions about the model.
Heuristically, the MSM approach provides an adjustment of the the treatment effect bias caused by the measured confounders. What one essentially does in the marginal structural model approach is that instead of modeling the underlying, and potentially very complicated, biology one models a randomized trial instead. The problem of computing marginal effects then splits into two parts: The first problem is to model the marginal intensity of the event in the simulated "randomized trial". If one knew the corresponding likelihood ratio process, then this would be obtainable using for instance the weighted additive hazard regression from the previous section. In order to compute this likelihood ratio one has to deal with the second part of our problem. That is to model the dynamics of the treatment and censoring processes given the full and the marginal history in the observational study. This is a crucial point. We have chosen not to deal with this problem in the current paper. However, one could use regression techniques to do this at least approximately. In the discrete time setting one typically uses pooled logistic regressions, see [SHL + 05] and [HBR00] . In the continuous time setting it is probably more natural to use additive hazard or Poisson regression to estimate the censoring and treatment intensities both with respect to the full covariate history and marginal covariate history. This will be the topic in future work. Once these intensities are known, one can compute the likelihood ratio process using (4.3).
